Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 42 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX studyTebbutt, N.; Wilson, K.; Gebski, V.; Cummins, M.; Zannino, D.; van Hazel, G.; Robinson, B.; Broad, A.; Ganju, V.; Ackland, S.; Forgeson, G.; Cunningham, D.; Saunders, M.; Stockler, M.; Chua, Y.; Zalcberg, J.; Simes, R.; Price, T.
2010Multimorbidity - not just an older person's issue. Results from an Australian biomedical studyTaylor, A.; Price, K.; Gill, T.; Adams, R.; Pilkington, R.; Carrangis, N.; Shi, Z.; Wilson, D.
2010Baseline factors predictive of serious suicidality at follow-up: findings focussing on age and gender from a community-based studyFairweather-Schmidt, A.; Anstey, K.; Salim, A.; Rodgers, B.
2010Assessment of atrial septal defects in adults comparing cardiovascular magnetic resonance with transoesophageal echocardiographyTeo, K.; Disney, P.; Dundon, B.; Worthley, M.; Brown, M.; Sanders, P.; Worthley, S.
2010Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.
2010Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with ImatinibWhite, D.; Dang, P.; Engler, J.; Frede, A.; Osborn, M.; Saunders, V.; Manley, P.; Zrim, S.; Hughes, T.
2010Global initiative for chronic obstructive lung disease stage 0 is associated with excess FEV₁ decline in a representative population sampleBrito-Mutunayagam, R.; Appleton, S.; Wilson, D.; Ruffin, R.; Adams, R.
2010Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetesAlbu, J.; Heilbronn, L.; Kelley, D.; Smith, S.; Azuma, K.; Berk, E.; Pi-Sunyer, F.; Ravussin, E.
2010Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgeryMetcalf, R.; Cleland, L.; Gibson, R.; Roberts-Thomson, K.; Edwards, J.; Sanders, P.; Stuklis, R.; James, M.; Young, G.
2010Obesity paradox during agingChapman, I.; Mobbs Patrick, C.; Hof, R.